Expression and purification of recombinant phenylalanine ammonia-lyase from Petroselinum crispum by Dima, Norbert A. et al.
STUDIA UBB CHEMIA, LXI, 2, 2016 (p. 21-34) 
(RECOMMENDED CITATION) 
 
 
 
 
EXPRESSION AND PURIFICATION OF RECOMBINANT 
PHENYLALANINE AMMONIA-LYASE FROM 
PETROSELINUM CRISPUM 
 
 
NORBERT ARTUR DIMAa, ALINA FILIPa, LÁSZLÓ CSABA BENCZEa, 
MÁRK OLÁHb, PÉTER SÁTORHELYIc, BEÁTA G. VÉRTESSYd,e, 
LÁSZLÓ POPPEb,f*, CSABA PAIZSa* 
 
 
ABSTRACT. In the present study the molecular cloning, expression and 
purification of recombinant PcPAL, with a cleavable N-terminal His-tag is 
described. The PcPAL gene was cloned into pET-19b vector and transformed 
to different E.coli host cells. The optimization of expression and purification 
processes provided recombinant protein with high purity in its native, tetrameric 
fold with a yield of 7-8 mg protein / 1 L culture. The activity of the recombinant 
protein was tested towards its natural substrate L-Phe, the KM, and kcat values 
suggesting excellent catalytic properties of the recombinant enzyme. 
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INTRODUCTION 
 
In higher plants, phenylalanine ammonia-lyase catalyses the conversion 
of L-phenylalanine to trans-cinnamic acid, the first step of the phenylpropanoid 
pathway. This process produces many secondary metabolites that fulfill many 
essential functions for plants growth and development, such as mechanical  
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support, pigment and flavonoid production [1,2]. PAL, the first enzyme involved in 
the metabolism of phenylpropanoid derivatives, has been extensively studied for 
its crucial function as a branch point between primary and secondary metabolism 
[3,4]. 
The currently known aromatic ammonia-lyases use an auto-catalytically 
formed 5-methylene-3,5-dihydro-imidazole-4-one (MIO) electrophilic prosthetic 
group, and show high structural and sequence similarities [5]. 
The recent advances in improving the functional properties of these 
enzymes increased both their biocatalytic and therapeutic applications. Sufficiently 
stable phenyalanine ammonia-lyases (PALs) are used in enzyme replacement 
therapy [6] of phenylketonuria (PKU) [7], or as a potential therapeutic enzyme in 
cancer treatment [8]. DSM company incorporated a recombinant PAL into the 
chemoenzymatic synthesis of (S)-2-indolinecarboxylic acid [9], a key intermediate 
for hypertension pharmaceuticals; while BASF (Germany) recently patented 
[10] hydroamination reactions catalyzed by recombinant PALs originating 
from Petroselinum crispum (PcPAL) and Rhodoturula glutinis (RgPAL). In the 
academic area the substrate scope of PcPAL was expanded to several aryl-, 
heteroaryl alanines [11,12,13] and even to the non-aromatic propargylglycine 
[14]. Furthermore the immobilization of PcPAL on single-walled carbon nanotubes 
[15] and magnetic nanoparticles [14,16] provided their successful employment 
for the synthesis of non-natural amino acid in continuous-flow microreactors. 
Therefore the importance of the large-scale production of recombinant PcPAL 
gained increased attention. Herein we describe the molecular cloning, expression, 
purification and large scale production of PcPAL. The purity, oligomerization state 
and the activity of the isolated enzyme suggest its correct, native-like tetrameric 
folding [17].  
 
 
RESULTS AND DISCUSSION 
 
Molecular cloning of recombinant PcPAL 
 
Based on the sequence of PcPAL (PDB code: 1W27) we designed a 
codon optimized gene sequence for expression in E.coli and for directional 
cloning into the pET-19b vector, using XhoI and BpuI1102I cloning sites. 
The designed gene sequence was obtained through gene synthesis 
services, and was cloned successfully into the expression vector, obtaining the 
novel recombinant plasmid encoding PcPAL (Figure 1a) with an N-terminal 
His10-tag and an enterokinase cleavage site, serving for the His-tag removal 
ulterior to protein purification. The recombinant plasmid was transformed through  
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heat-shock into different E.coli competent cells in order to optimize the expression 
yields. The successful outcome of the cloning and transformation step was 
determined by agarose gel electrophoresis (Figure 2).  
 
 
 
Figure 1. The genetic map of the 
created recombinant plasmid containing 
the gene encoding PcPAL and the 
amino acid sequence of the designed 
recombinant PcPAL.  
 
 
Figure 2. Agarose gel electropho-
resis. L: DNA Ladder, 1. circular 
plasmid DNA, extracted from colo-
nies obatined after transformation in 
Rosetta (DE3) pLysS cells, 2. Plas-
mid DNA from 1, digested with re-
striction enzymes XhoI and Bpu1102I. 
 
 
Optimization of PcPAL overexpression in E.coli 
 
Further we performed the optimization of overexpression in E.coli, 
studying the influence of the nature of host cells (E.coli Rossetta, BL21, C41 all 
with (DE3), pLysS modifications), of the inducer (IPTG) concentration and of 
the temperature upon the expression levels of the PcPAL. Varying the 
concentration of IPTG, expression of proteins can be regulated at different 
levels, lower level expression can increase the solubility and activity of the 
target proteins [18] For the optimization of PcPAL expression, the effect of 
different concentrations of inducer (0.1, 0.5 and 1 mM IPTG) was tested on 
the growing culture of BL21(DE3)pLysS containing the pET-19b-PcPAL 
recombinant plasmid and the cells before and after induction were analyzed 
by SDS-PAGE. No significant difference was observed in the PcPAL protein 
expression levels of the differently induced cells, therefore the lowest 0.1 mM 
IPTG concentration was used in further experiments. 
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The effect of the nature of host E.coli cells proved to be crucial, in 
BL21 and C41 the yields of the isolated protein were low, while in Rosetta 
20-30 mg PcPAL / liter ferment was obtained. This might be due to the fact 
that Rosetta encodes for a larger number of rare-codons than BL21 and 
C41 [19], providing successful translation of the recombinant gene. 
To evaluate the effect of growth temperature on the expression of 
PcPAL after induction, the cultures were incubated at different temperatures 
(18, 25, and 37°C). Initially the cell cultures were incubated at 37°C. After 
the density of cells reached OD600 ~0.6 (approx. 4 h) the temperature was 
reduced (to 18 or 25°C) and the cultures were induced with 0.1 mM IPTG. 
The density of the cells was monitored in time (Figure 3), the maximum 
yield of enzyme being obtained in case of 25°C incubation temperature, with 
an optimal post-induction time of 12-14 h, where the cell growth reaches the 
stationary phase. 
Therefore the optimal overexpression conditions E.coli Rosetta 
(DE3)pLysS as host strain, 0.1 mM IPTG and 25oC fermentation temperature 
were further used for the large scale (10 L) production of the enzyme. 
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Figure 3. Effect of growth temperature on the expression of PcPAL. 
 
 
Production, purification and characterization of recombinant PcPAL 
 
 After overexpression optimization, the production and purification of  
the recombinant PcPAL protein was performed. The N-terminal (His)10-tag of 
the protein allows affinity purification with Ni-NTA resin. Ni–NTA affinity 
chromatography is a rapid and easy purification technique for proteins fused 
with His-tag at either ends (N- or C-terminus). The strong binding between 
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His-tag and the immobilized nickel ions allows easy washing and efficient 
elution of bounded His-tagged protein by competition with imidazole [20]. 
 Performing the Ni-NTA purification, the protein fraction eluted with 
250 mM imidazole, besides the PcPAL protein (81 kDa), contains additional 
proteins with lower molecular weight (Figure 4, lane 6). Despite our optimization 
efforts (varying the imidazole concentration of the elution buffer, introducing 
intermediate washing steps with high and low salt concentration buffers, 
according to the manufacturer description [21]) the protein purity, determined 
by SDS-PAGE remained below 80%. 
 
 
 
 
 
 
 
 
 
 
Figure 4. SDS-PAGE gel containing samples from the purification steps of PcPAL:  
1: before induction; 2: after induction; 3: supernatant after centrifugation of the lysate; 
4: flow through after application; 8: low salt; 5: 25mM fraction of imidazole;  
6: 400mM fraction of imidazole; 7: fraction eluted at 10-12 mL from the  
column; 8: fraction eluted at 14-16 mL from the column; 9: marker.  
Samples were prepared as described in the experimental section. 
 
 In order to increase the purity of the isolated PcPAL we introduced 
additional chromatographic purification steps. Due to the large difference in 
the molecular weights of the target protein and of the other, unwanted protein 
impurities we opted for size-exclusion chromatography, using a Superdex 
200 10/300 GL. This chromatography step also allows the determination of 
the oligomerization state of the protein, and thus the homogeneity of the 
isolated protein [22]. This is crucial since different oligomerization states of 
the same protein (including aggregated forms of the protein) on SDS-PAGE 
cannot be distinguished, they migrate at the same molecular weight 
corresponding to the monomer however their enzyme activity can significantly 
differ. Thus, besides the separation of the protein impurities, the SEC method 
will provide additional results related to the correct, native-like oligomerization 
state of the isolated protein. 
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 Performing the SEC purification of the fraction eluted with 250 mM 
imidazole from the Ni-NTA column, several protein peaks were eluted (Figure 5). 
The identity of the protein peaks eluted was determined by SDS-PAGE 
(Figure 4, lane 7-8). These results show that the protein fractions eluted at 8.4 
and 11.2 mL retention volumes are pure PcPAL proteins, presumably having 
different oligomerization states. In order to determine the molecular weight 
determination by SEC the comparison of an elution volume parameter, such 
as Kav of the protein of interest, with the values obtained for several known 
calibration standards (Table 1) should be done [23]. 
 
 
 
 
Figure 5. Purification of PcPAL on Superdex 200 10/300 GL size-exclusion column. 
 
 
Thus the molecular weight of an unknown protein can be determined 
from the calibration curve (Figure 6, plot of Kav versus the logarithm of molecular 
weight) once its Kav value is calculated from its measured elution volume [23]. 
Accordingly the molecular weight of the PcPAL protein fractions 
eluted were estimated to be 355 kDa for the peak eluted at 11,2 mL and  
> 600 kDa for the fraction eluted at 8,4 mL, corresponding to the presumed 
native tetrameric and higher oligomerization states (octameric or even higher 
aggregated forms) of the protein, respectively. 
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Table 1. Elution volume parameters Kav of standard globular  
proteins used for the calibration curve set-up 
 
Protein standard Mol. weight (Da) 
Volume of elution 
(Ve) (mL) Kav* LogMW 
Thyroglobulin 669000 8,26 0,074 5,83 
Ferritin 440000 10,56 0,209 5,64 
Aldolase 158000 12,38 0,316 5,20 
BSA 67000 13,9 0,406 4,83 
Ovalbumin 45000 15,08 0,475 4,65 
Chimotrypsinogen A 25000 17,21 0,601 4,40 
 Kav = (Ve-Vo)/(Vc-Vo); Vc = 24 mL (column volume); Vo = 8.1 mL (column void volume) 
 
 
 
Furthermore we compared the enzyme activities of the presumed 
largely aggregated and tetrameric forms of PcPAL, separated by size-
exclusion chromatography, towards the natural substrate L-Phe. Performing 
the experiment at 1 mM substrate concentration, we observed three times 
higher activity for the presumed native, tetrameric form of the protein.  
ݒ௧௘௧௥௔௠௘௥
ݒ௔௚௚௥௘௚௔௧௘ ൌ
3,409 ∗ 10ିଶሾߤܯݏ ሿ
1,149 ∗ 10ିଶሾߤܯݏ ሿ
≅ 3 
 These results directed us to optimize the isolation and purification 
procedure in order to achieve high yields for the production of the PcPAL 
tetramer. The presence of higher oligomerization states of the protein might 
be the results of aggregation processes, caused by the presence of free thiol 
NORBERT ARTUR DIMA, ALINA FILIP, LÁSZLÓ CSABA BENCZE, MÁRK OLÁH ET AL. 
 
 
 
28 
groups, able to form intermolecular disulphide bridges, or hydrophobic 
aggregation processes, caused by high protein or salt concentration in the 
solution [24]. Furthermore the removal of the 35 kDa protein impurity during 
isolation steps is also preferable for yield and purity increasements. This protein 
band coelutes with PcPAL at the Ni-affinity purification step, furthermore during 
longer incubation times (>4 hours) its amount increases in the protein sample 
(checked by SDS-PAGE), suggesting that it is PcPAL fragment, containing the 
N-terminal His10-tag, obtained by proteolytic degradation.  
 Therefore in order to alleviate these problems several modification 
were introduced in the isolation and purification protocol: i) the imidazole 
concentration used for the elution at the Ni-affinity chromatography was 
decreased, ii) the concentration steps of the solutions with high imidazole 
content were avoided, performing the protein concentration step after the 
removal of the imidazole with SEC chromatography or dialysis, iii) the use 
of protease inhibitor cocktail (mini-tablets from Roche) during all isolation 
and purification steps. These modifications provided an optimal isolation and 
purification procedure for the recombinant PcPAL, resulting in protein with high 
purity (> 95% on SDS-PAGE, Figure 8) and presumable in its native, tetrameric 
fold (Figure 7). 
 
 
Figure 7. FPLC chromatogram of the pure tetramer obtained  
with the optimized procedure. 
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Figure 8. SDS-PAGE gel containing samples from the purification steps of PcPAL:  
1: before induction; 2: after induction; 3: supernatant of cells; 4: cell lysate 5: pellet of the  
cell lysate; 6: supernatant after centrifugation of the lysate; 7: flow through after application;  
8: low salt; 9: high salt; 10: low salt; 11: 25mM fraction of imidazole; 12: 400mM fraction of 
imidazole (pure elute); 13: 1M fraction of imidazole; 14: fraction eluted at 10-12 mL from the 
column and 15: marker. Samples were prepared as described in the experimental section. 
 
 
 
 
Figure 9. SDS-PAGE gel containing samples from the purification steps of PcPAL 
with the support Dv1000-EDTA-La: 1: marker; 2: flow through after application;  
3: low salt; 4: high salt; 5: low salt; 6: 5 mM fraction of EDTA 7:  25 mM fraction  
of EDTA; 8: 50 mM fraction of EDTA; 9: 100 mM fraction of EDTA; 10: empty. 
Samples were prepared as described in the experimental section. 
 
Besides the commercially available Qiagen Ni-NTA affinity 
chromatography resin another silica based support was investigated with 
the optimized purification procedure of (His)10-tagged PcPAL. This product 
allows purification of recombinant proteins through its high surface area 
(>100 m2/g) and mesoporous structure (100 nm) in addition strong binding 
capability between the His-tag and EDTA-immobilized lanthanum ions. The 
purification method was performed in batch mode by shaken the suspension 
of support (Dv1000-EDTA-La) and supernatant of the centrifuged cell lysate. 
Thereafter the nonspecific proteins were desorbed by buffers (Figure 9, 
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lane 3-4) and the target protein, PcPAL was eluted by gradient elution with 
different concentration of EDTA solutions and given in high purity (> 95% 
on SDS-PAGE, Figure 9, lane 6-8). The purity and yields of the isolated 
protein were in similar range as those obtained from the Ni-NTA affinity 
purification (7-8 mg protein / 1 L culture). 
Further we determined the activity of the recombinant PcPAL towards 
its natural substrate L-Phe and compared the values with those obtained in 
the literature [6,7,8,14].  
 The activity measurements were performed by UV-monitoring the 
production of acrylic acid at 290 nm. The obtained KM value of 116 ± 4 and 
kcat value of 1±0.05 were highly reproducible and suggested better catalytic 
properties of the enzyme than those described in the literature [11,12,25]. 
The Michaelis-Menten plot of the measurement using the purified enzyme 
is shown at Figure 10. The KM, vmax and kcat values were determined using 
the Lineweaver-Burk plot (Figure 11). 
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CONCLUSIONS 
 
During this study we report the successful cloning, expression and 
isolation of recombinant PcPAL with a removable N-terminal His10-tag. The 
oligomerization state of the expressed protein was determined with size-
exclusion chromatography and suggested that the tetrameric PcPAL is the 
most active oligomerization form. Optimization of the isolation and purification 
protocol provided pure, homogeneous PcPAL tetramer, with excellent and 
reproducible catalytic activities. 
 
 
EXPERIMENTAL SECTION 
 
Materials and methods 
 
IPTG, tetracycline, chloramphenicol, carbenicillin, imidazole, Tris,HCl, 
phenylalanine, LB medium, tryptone, yeast extract, NaCl, KCl, NaH2PO4, 
Na2HPO4, EDTA, SDS, TEMED, glycerol, β-mercaptoethanol, Coomassie 
Brilliant Blue, FastRulerTM High Range DNA Ladder, Lysozyme, DNAse, 
RNAse are reagents used in experiments and were purchased from companies 
Sigma, Aldrich, Carl Roth GmbH, Poch, Liofilchem or ThermoFischer. The gel 
filtration calibration protein kit were purchased from GE Healthcare, while the 
Complete Protease Inhibitor Cocktail Tablets from Roche. E. coli host strains, 
XL1-Blue, BL21(DE3)pLysS, Rosetta (DE3)pLysS and C41(DE3)pLysS were 
purchased from Novagen. 
The kinetic measurements were performed on a Varian Cary 50 and on 
an Agilent 8453 UV-Vis Spectrophotometer. The gel filtration purifications were 
made on a Ӓkta purifier fast protein liquid chromatograph with autofractioner. 
 
Molecular cloning and expression optimization 
 
The gene encoding phenyalanine ammonia-lyase from Petroselinum 
crispum has been codon optimized for bacterial expression in E. coli. (Figure 2). 
The synthetic gene produced by Life Technologies was introduced into the 
pET-19b vector using the XhoI and Bpu1102I cloning sites, for expression with 
an N-terminal (His)10-tag and an enterokinase cleavage site, for His-tag removal.  
The obtained plasmid was transformed in E.coli XL1-Blue competent 
cells by heat shock as well as in different E.coli host strains (Rosetta 
(DE3)pLysS, BL21(DE3)pLysS, C41(DE3)pLysS) in order to optimize the 
expression yields. 
Different concentrations of IPTG (0.1 mM, 0.5 mM and 1 mM) and 
different fermentation temperatures (25°C, 30°C and 37°C) were tested during 
the expression optimization. 
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Expression and production of the recombinant PcPAL –  
optimized procedure 
 
The recombinant plasmids which contains a N-terminal (His)10-tag 
were produced in E. coli  Rosetta(DE3)pLysS cells using LB media supplemented 
with the carbenicillin and chloramphenicol.  
Batch mode fermentation: First a preculture was prepared by the 
inoculation of 100 mL of sterile LB medium, containing carbenicillin (50 µg/mL) 
and chloramphenicol (30 µg/mL) with the bacterial cells from the agar plate, 
followed by overnight incubation at 37°C and shaking at 200 rpm. 8 × 0.5 L of 
LB medium (in 2 L flasks) was inoculated with 2% (v/v) of the preculture and 
grown at 37°C, 200 rpm until OD600 reached 0.7-0.8. Protein expression was 
induced via the addition of 0.1 mM IPTG, and the cell growth was maintained 
at 25°C for another 12 h, reaching an OD600 value of 3.4-3.6  
Large scale fermentation of the recombinant PcPAL: ten litres of 
Terrific broth (TB) medium were sterilized at 121°C, 1.2 bar for 25 min. After 
sterilization, the media was cooled down to 37°C and ampicillin was added to 
the fermentation broth for a final concentration of 100 µg/mL. The fermentation 
media was inoculated with 100 mL of the overnight seed culture of the E. coli 
producer strain. The following fermentation parameters were set up: temperature 
at 37°C, agitation 300 rpm, overpressure 0.2-0.5 bar and bottom air inlet 5 L/min. 
The pH value of the fermentation broth was controlled at pH 7.1±0.1. The 
dissolved oxygen (DO) value was set to a minimum of 30% and was controlled 
by the stirring speed. When the OD600 of the culture reached 0.8±0.1, the 
temperature was set to 25°C and the culture was induced with IPTG (0.1 mM 
final concentration). The fermentation broth was harvested after 21 h, when 
the culture reached the stationary growth phase. 
 
Purification of the recombinant PcPAL – optimized procedure 
 
Cells were harvested by centrifugation (30 min, 2000 × g, 4500 rpm); 
followed by their resuspension (with vortex and pipetting) in 100 mL lysis 
buffer (50 mM Tris.HCl, 300 mM NaCl, 0.5 mM EDTA; pH 8) supplemented 
with RNAse (3 mg), Lysozyme (10 mg), PMSF (20 mg/ 1 mL EtOH) and one 
tablet from the protease inhibitor cocktaile of Roche. The cells were lysed by 
sonication (2 sec pulse, 40% intensity, 30 min, T < 20 0C) and the cell debris, 
respectively membrane fractions were removed by centrifugation (24000 × g, 
15000 rpm, 35 min). The supernatant was loaded on Ni-NTA affinity 
chromatography, using appoximately 2 mL of Ni-NTA superflow resin from Qiagen 
and using the protocol described by the manufacturer. The PcPAL protein with the 
N-terminal His-tag eluted with the 400 mM imidazole fraction. The protein was 
4 × fold concentrated through amicons with 10 kDa cut-off, followed by their 
further purification with size-exclusion chromatography, using Superdex 200 
10/300 GL column and 20 mM Tris,150 mM NaCl, pH 7.5 buffer as eluent. The 
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homotetrameric protein eluted at 10.5-12 mL retention volumes. The protein was 
stored until further use at -20 0C, with 10% glycerol. 
 
Purification with Dv1000-EDTA-La support – alternative procedure 
 
The Dv1000-EDTA-La [26] support (100 mg) was dispersed in 1 mL 
lysis buffer (50 mM Tris.HCl, 300 mM NaCl, 0.5 mM EDTA, pH 8.0) and the 
suspension was shaken (10 min, 350 rpm). Thereafter 1 mL of centrifuged 
supernatant of cell lysate was added and shaken further (30 min, 350 rpm). 
This suspension was centrifuged (3 min, 3500 rpm) and the supernatant 
was removed. Then the support was shaken (10 min, 350 rpm) with the 
following solutions and between two fractions the supernatant was removed 
after centrifugation: low salt buffer (50 mM HEPES, 30 mM KCl, pH 7.5), high 
salt buffer (50 mM HEPES, 300 mM KCl, pH 7.5), low salt buffer and four 
different concentration ethylenediaminetetraacetic acid disodium dihydrate 
solutions (5, 25, 50, 100 mM of disodium salt of EDTA and 50 mM HEPES, 30 
mM KCl, pH 8.0). The fractions were investigated by SDS-PAGE. 
SDS-PAGE electrophoresis was performed according to the 
Laemmli-protocol [27] using acrylamide gels.  
Samples were taken for every step of the expression and purification 
stage and prepared by denaturation at 95°C for 5-10 min with addition of 
reducing 3x sample buffer.  
Enzyme activity measurements: Activity of PcPAL was determined 
spectrophotometrically by monitoring the production of trans-cinnamic acid 
at 290 nm for 10 min, using Quartz cuvettes of 1.4 mL. The measurements 
were performed at 37°C for 10 min, in presence of 30 μg of enzyme, 
varying the substrate concentration between 0.03-1.5 mM. Kinetic constants 
(KM and vmax) were obtained by determining the initial rate of reactions at 
different substrate concentrations. The extinction coefficient (ε) was determined 
in 0.1 M Tris-buffer (pH 8.8) at 290 nm: ε290=8.8 mM-1×s-1. 
 
ACKNOWLEDGMENTS 
 
This work was possible due to the financial support of the Sectorial 
Operational Program for Human Resources Development 2007-2013, co-financed 
by the European Social Fund, under the project number POSDRU/159/1.5/S/ 
132400 with the title „Young successful researchers – professional development 
in an international and interdisciplinary environment”. This work was also 
supported by the Romanian National Authority for Scientific Research and 
Innovation, CNCS-UEFISCDI, project number PN-II-RU-TE-2014-4-1668, by the 
Hungarian OTKA Foundation (Project NN-103242), by the New Hungary 
Development Plan (Project TÁMOP-4.2.2.B-10/1–2010–0009), by the Hungarian 
Research and Technology Innovation Fund (KMR 12-1-2012-0140) and by the 
EU COST (Action CM1303 “SysBiocat”). 
NORBERT ARTUR DIMA, ALINA FILIP, LÁSZLÓ CSABA BENCZE, MÁRK OLÁH ET AL. 
 
 
 
34 
REFERENCES 
 
[1] M. WenLi, W. Min, R. ZhuMei, Z. Yang, Plant Cell Reports, 2013, 32, 1179. 
[2] G. Jihai, et al., Molecular Biology Reports, 2012, 39, 3443. 
[3] T. Vogt, Molecular Plant, 2010, 3, 2. 
[4] C.M. Fraser, C. Chapple, The Arabidopsis Book, 2011, e0152. 
[5] L. Poppe, J. Rétey, Current Organic Chemistry, 2003, 7, 1297. 
[6] C. W. Abell, D. S. Hodgins, W. J. Stith, Cancer Research, 1973, 33, 2529. 
[7] A. Belanger-Quintana, A. Burlina, C.O. Harding, A.C. Muntau, Molecular 
Genetics and Metabolism, 2011, 104(Suppl), S19. 
[8] O.O. Babich, V.S. Pokrovsky, N.Y. Anisimova, N.N. Sokolov, A.Y. Prosekov, 
Biotechnology and Applied Biochemistry, 2013, 60, 316. 
[9] B. de Lange, D.J. Hyett, P.J.D. Maas, D. Mink, F.B.J. van Assema, et al., 
ChemCatChem, 2011, 3, 289. 
[10] B. Hauer, N. Schneider, D. Drew, K. Ditrich, N. Turner, B.M. Nestl, US patent, 
2012, US2012/0123155A1. 
[11] A. Gloge, J. Zon, A. Kővári, L. Poppe, J. Rétey, Chemistry - A European Journal, 
2000, 6, 3386. 
[12] C. Paizs, A. Katona, J. Rétey, Chemistry - A European Journal, 2006, 12, 2739. 
[13] C. Paizs, A. Katona, J. Rétey, European Journal of Organic Chemistry, 2006, 
1113. 
[14] D. Weiser, L.C. Bencze, G. Bánóczi, F. Ender, R. Kiss, E. Kókai, A. Szilágyi, B.G. 
Vértessy, O. Farkas, C. Paizs, L. Poppe, ChemBioChem, 2015, 16, 2257. 
[15] J.H. Bartha-Vári, M.I. Toșa, F.D. Irimie, D. Weiser, Z. Boros, B.G. Vértessy, C. 
Paizs, L. Poppe, ChemCatChem, 2015, 7, 1122. 
[16] F. Ender, D. Weiser, B. Nagy, L.C. Bencze, C. Paizs, P. Pálovics, L. Poppe, 
Journal of Flow Chemistry, 2016, 6(1), 43–52. 
[17] H. Ritter, G.E. Schultz, Plant Cell, 2004, 16, 3426. 
[18] J. Sambrook, D.W. Russell, Molecular Cloning a Laboratory Manual. 3rd 
Edition, New York: Cold Spring Harbor Laboratory Press, 2001. 
[19] Novagen, User Protocol TB009 Rev. F 0104, 1. 
[20] J. Crowe, H. Dobeli, R. Gentz, E. Hochuli, D. Stiber, and K. Hence, Methods 
in Molecular Biology, 1994, 31, 371. 
[21] Ni-NTA Agarose Purification of 6xHis-tagged Proteins from E. coli under 
Native Conditions, Quick-Start Protocol, Qiagen, 2011. 
[22] E.R.S. Kunji, M. Harding, P.J.G. Butler, P. Akamine, Methods, 2008, 46, 62. 
[23] GE Healthcare - Gel Filtration Calibration Kits, Product booklet. 
[24] M. Lebendiker, T. Danieli, FEBS Letters, 2014, 588, 236. 
[25] a) D. Röther, L. Poppe, G. Morlock, S. Viergutz, J. Rétey, European Journal of 
Biochemistry, 2002, 269, 3065; b) L. Poppe, J. Rétey, Angewandte Chemie 
International Edition, 2005, 44, 3668; c) S. Bartsch, U.T. Bornscheuer, Protein 
Engineering, Design & Selection, 2010, 1; d) M.I. Toșa, J. Brem, A. Mantu, 
F.D. Irimie, C. Paizs, J. Rétey, ChemCatChem, 2013, 5, 779; e) S.L. Lovelock, 
N.J. Turner, Bioorganic & Medicinal Chemistry, 2014, 22, 5555. 
[26] L. Poppe, Z. Boros, B.G. Vértessy, K. Kovács, A. Tóth, G. Hornyánszky, J. Nagy, 
B. Erdélyi, V.E. Bódai, P. Sátorhelyi., WO 179072 A1, 2013. 
[27] U.K. Laemmli, Nature, 1970, 227, 680. 
